Abstract:Background: Protein arginine methyltransferase 5 (PRMT5) is a type II arginine methyltransferase that symmetrically di-methylates arginine residues on both histone and non-histone protein substrates. Accumulating evidence suggests that PRMT5 exerts its oncogenic properties in a wide spectrum of human malignancies. However, the underlying mechanisms by which PRMT5 contributes to the progression of colorectal cancer (CRC) remain to be defined.Methods: Western blot and real-time PCR were used to analyze the expression of CDKN2B. Co-immunoprecipitation (Co-IP), immunofluorescence and GST pulldown assays were employed to investigate the interaction between PRMT5 and EZH2. Luciferase reporter and chromatin immunoprecipitation (ChIP) assays were performed to validate CDKN2B as a direct target of PRMT5/EZH2. DNA methylation status at the CpG islands of promoter region of CDKN2B gene was analyzed by bisulfite sequencing. The effect of PRMT5/EZH2 on malignant phenotypes was examined through in vitro and in vivo assays. PRMT5 and EZH2 protein expression levels in CRC tissues were analyzed by immunohistochemistry (IHC) staining.Results: We observed that PRMT5-deficient CRC cells exhibit proliferation defects in vitro. PRMT5 was identified as a major transcriptional repressor of CDKN2B (p15INK4b) for determining CRC progression. Mechanistically, PRMT5-mediated histone marks H4R3me2s and H3R8me2s were predominantly deposited at the promoter region of CDKN2B gene in CRC cells. Knockdown of PRMT5 in CRC cells decreased the accumulation of H4R3me2s and H3R8me2s marks and reduced the CpG methylation level of CDKN2B promoter, then re-activated CDKN2B expression. Strikingly, silencing of CDKN2B partially abrogated the proliferation defects caused by PRMT5 depletion in vitro and in vivo. Furthermore, we proved that PRMT5 interacted with Enhancer of zeste homolog 2 (EZH2), leading to enhanced EZH2 binding and H3K27me3 deposition together with decreased transcriptional output of CDKN2B gene. Importantly, we found that the combined interventions exerted a synergistic inhibitory effect of combined treatment with PRMT5i (GSK591) and EZH2i (GSK126) on the growth of CRC cells/xenografts in vitro and in vivo. Moreover, PRMT5 and EZH2 were found to be significantly elevated and associated with poor prognosis in CRC patients.Conclusion: PRMT5 functionally associates with EZH2 to promote CRC progression through epigenetically repressing CDKN2B expression. Thus, our findings raise the possibility that combinational intervention of PRMT5 and EZH2 may be a promising strategy for CRC therapy.

Caenorhabditis Elegans Protein Arginine Methyltransferase PRMT-5 Negatively Regulates DNA Damage-Induced Apoptosis

Arginine Methylation of Hnrnp K Enhances P53 Transcriptional Activity.

The E3 Ligase Ring1 Targets P53 For Degradation And Promotes Cancer Cell Proliferation And Survival

The protein arginine methyltransferase PRMT5 regulates Aβ-induced toxicity in human cells and Caenorhabditis elegans models of Alzheimer's disease

Translational Repression of C. Elegans P53 by GLD-1 Regulates DNA Damage-Induced Apoptosis

WITHDRAWN: Caenorhabditis Elegans Nuclear Hormone Receptor NHR-14, Cooperates with P53/cep-1 to Regulate DNA Damage-Induced Apoptosis

Ribosome Synthesis and MAPK Activity Modulate Ionizing Radiation-Induced Germ Cell Apoptosis in Caenorhabditis Elegans.

Essential Roles of P53 and MAPK Cascades in Microcystin-LR-Induced Germline Apoptosis in Caenorhabditis Elegans

Genome-wide RNAi identifies p53-dependent and -independent regulators of germ cell apoptosis in C. elegans

The Epigenetic Modifier PRDM5 Functions As a Tumor Suppressor Through Modulating WNT/β-catenin Signaling and is Frequently Silenced in Multiple Tumors.

PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression

Ceramide Mediates Radiation-Induced Germ Cell Apoptosis Via Regulating Mitochondria Function and MAPK Factors in Caenorhabditis Elegans.

Caenorhabditis Elegans NHR-14/HNF4α Cooperates with cep-1/ p53 to Regulate DNA Damage-induced Apoptosis

Late Cornified Envelope Group I, a Novel Target of p53, Regulates PRMT5 Activity

Caenorhabditis Elegans NHR-14/HNF4α Regulates DNA Damage-Induced Apoptosis Through Cooperating with Cep-1/P53

Arsenite-induced germline apoptosis through a MAPK-dependent, p53-independent pathway in Caenorhabditis elegans.

MRG-1 is required for genomic integrity in Caenorhabditis elegans germ cells

Arginine Methyltransferase PRMT1 Regulates p53 Activity in Breast Cancer

Cadmium-induced germline apoptosis in Caenorhabditis elegans: the roles of HUS1, p53, and MAPK signaling pathways.

Regulation of CED-3 Caspase Localization and Activation by C. Elegans Nuclear-Membrane Protein NPP-14

Cereblon Attenuates DNA Damage-Induced Apoptosis by Regulating the Transcription-Independent Function of P53